+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharming Group NV - logo

The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

From
From
From
Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025 - Product Thumbnail Image

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025

  • Report
  • September 2025
  • 300 Pages
  • Global
From
From
Gaucher Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gaucher Disease Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Acute Ischemic Stroke - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Ischemic Stroke - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
C1-INH Replacement Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

C1-INH Replacement Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 189 Pages
  • Global
From
From
Gaucher'S Disease Market Report 2025 - Product Thumbnail Image

Gaucher'S Disease Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Complement C1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ischemia Reperfusion Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Ischemia Reperfusion Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 197 Pages
  • Global
From
From
From
Loading Indicator